Edward O'Neill (@nuclearmeded) 's Twitter Profile
Edward O'Neill

@nuclearmeded

PCUK Career Acceleration Fellow @UniofOxford šŸ‡¬šŸ‡§ working to improve radionuclide treatment of prostate cancer with novel drug combinationsšŸ’Š+ā˜¢ļø.

ID: 1254044175202426883

calendar_today25-04-2020 13:46:54

139 Tweet

340 Followers

350 Following

Nuffield Department of Surgical Sciences (@ndsurgicalsci) 's Twitter Profile Photo

We are thrilled to announced that Dr Edward O'Neill will join our department after securing a prestigious Prostate Cancer UK Career Acceleration Fellowship. Congrats and welcome to NDS, Edward O'Neill! šŸŽ‰ āž”ļø nds.ox.ac.uk/news/edward-on… ProstateUK Profs Prostate Cancer UK Press @ProstateUK

We are thrilled to announced that Dr Edward O'Neill will join our department after securing a prestigious Prostate Cancer UK Career Acceleration Fellowship. Congrats and welcome to NDS, <a href="/NuclearMedEd/">Edward O'Neill</a>! šŸŽ‰

āž”ļø nds.ox.ac.uk/news/edward-on…

<a href="/ProstateUKProfs/">ProstateUK Profs</a> <a href="/ProstateUKPress/"><a href="/ProstateUK/">Prostate Cancer UK</a> Press</a> @ProstateUK
Edward O'Neill (@nuclearmeded) 's Twitter Profile Photo

Postdoc/RA jobs in new #radiobiology group Roberto Rodriguez •Funder PCF Science •Co-supervision Claire Edwards šŸ’™ •Collab with Oxford Prostate Cancer Biology Group Project: Identify metabolic signatures in #prostatecancer 🦓 mets w/ PET imaging for tailored šŸ’Š + ā˜¢ļøcombos t.ly/3iIrL Cl 17 Jan

Postdoc/RA jobs in new #radiobiology group <a href="/unioxford/">Roberto Rodriguez</a>

•Funder <a href="/PCF_Science/">PCF Science</a>
•Co-supervision <a href="/ProfClaireEd/">Claire Edwards šŸ’™</a> 
•Collab with <a href="/OxPCaBiol/">Oxford Prostate Cancer Biology Group</a> 
 
Project: Identify metabolic signatures in #prostatecancer 🦓 mets w/ PET imaging for tailored šŸ’Š + ā˜¢ļøcombos

t.ly/3iIrL

Cl 17 Jan
Edward O'Neill (@nuclearmeded) 's Twitter Profile Photo

Reminder there is still time to apply (closing tomorrow, 17th January) for these positions on an exciting project to determine how prostate cancer metabolism affects its radioresistance against 177LuPSMA and more importantly how to overcome this resistance.